Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedRecruitment status now indicates the study is no longer enrolling participants. New user guidance pages and a refined Intervention/Treatment header were added to help users navigate and interpret the study details.SummaryDifference0.5%

- Check12 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a small platform update. This change does not alter the study details or visible content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe revision label changed from v3.5.3 to v3.5.4, indicating a small update to the study record. This appears to be a metadata or documentation update rather than a substantive change to the study data or eligibility criteria.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision label on the page updated from v3.5.2 to v3.5.3. This represents a minor update to the page template and does not change the study details or data presented.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the page footer as part of a site update.SummaryDifference0.1%

- Check90 days agoChange DetectedPage revision history updated: v3.4.3 was removed and v3.5.0 was added.SummaryDifference0.1%

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.